Abstract
Cytomegalovirus (CMV) encephalitis is a rare infection that immunodeficient patients, mainly where HIV-positive, may suffer from. Several cases were described when complications with the treatment with monoclonal antibodies, like rituximab, for malignant lymphomas. We will describe here the case of a patient, who has developed CMV gastritis, then CMV encephalitis after the treatment of a CLL with a chemotherapy and maintenance therapy with rituximab.
MeSH terms
-
Aged
-
Antibodies, Monoclonal, Murine-Derived / adverse effects*
-
Antibodies, Monoclonal, Murine-Derived / therapeutic use
-
Antibodies, Viral / analysis*
-
Antineoplastic Agents / adverse effects
-
Antineoplastic Agents / therapeutic use
-
Cytomegalovirus / immunology*
-
Cytomegalovirus Infections / diagnosis
-
Cytomegalovirus Infections / etiology*
-
Follow-Up Studies
-
Humans
-
Leukemia, Lymphocytic, Chronic, B-Cell / drug therapy*
-
Male
-
Rituximab
-
Severity of Illness Index
Substances
-
Antibodies, Monoclonal, Murine-Derived
-
Antibodies, Viral
-
Antineoplastic Agents
-
Rituximab